Skip to main content

Research Repository

Advanced Search

Dr Alpana Mair's Recognition (113)

Implementing the WHO Third Global Patient Challenge: Flagship Reports, WHO Patient Safety Collaborative. Key Note.
2021

Description Invited by WHO HQ to speak on the Flagship reports of the WHO Global Patient Safety Challenge: Medication without Harm
Research Areas Public health
Research Themes Health

Innovative Polypharmacy – optimising polypharmacy management through educational and workforce development including the iSIMPATHY 7-Steps training. National Education For Scotland
2024

Description NES healthcare professionals conference
Research Themes Health

Person Centred Approach to improve wellbeing and outcomes from medicines: iSIMPATHY International Foundation of Integrated Care, ICIC 24, Northern Ireland
2024

Description iSIMPATHY ( implementing Stimulating innovation in the Management of Polypharmacy and Adherence Through the Years) builds on the findings of the EU project, SIMPATHY and the Scottish national implementation of a program to address inappropriate prescribing and prevent medication related Harm. Program aims were to ensure the most sustainable use of medicines for patients by training pharmacists, doctors and wider healthcare professionals to deliver person-centred medicines reviews and embedding a shared approach to managing multiple medicines. This program has delivered on its key policy objectives by improving patient outcomes, safety and engagement with their medication regimens by fully adopting the “what matters to me” approach across the considering an integrated approach.
Research Areas Health and wellbeing
Public health
Research Themes Health
Environment

Treat the Person, Save the Planet, Key Note, European Society of Clinical Pharmacists, Warsaw, Poland
2024

Description Invited by the European Society of Clinical Pharmacists:
Inappropriate polypharmacy and adherence impact adversely on both population health and quality of life and health system burden and costs. The EU-funded SIMPATHY project identified recommendations to manage polypharmacy in Europe, building on implementation of a Scottish programme addressing inappropriate prescribing and prevent medication-related harm. iSIMPATHY (implementing Stimulating innovation in the Management of Polypharmacy and Adherence Through the Years) sought to implement these SIMPATHY findings in Scotland, Northern Ireland and Ireland. The approach centred around patient partnership, “what matters to me” and shared decision making in medicines reviews using the 7-Step approach.

The project demonstrated the feasibility of embedding a standardised approach to medicines review in Northern Ireland and Ireland and scaling up the Scottish work. Application of change management methodology and shared decision making as part of a person centred approach to pharmacist-led medicines use review delivery in multiple healthcare settings, with multidisciplinary team (MDT) collaboration, ensured the most sustainable use of medicines in both cost and environmental impact.
The project increased workforce capacity capability through training healthcare professionals is available that is accredited for all healthcare professional by the Royal College of Physicians UK.
iSIMPATHY was welcomed by patients and MDT colleagues and demonstrated economic dominance across care settings and three jurisdictions.

•6,481 patients engaged in reviews in primary care, secondary care, outpatient clinics and care homes.
•An average of 11 interventions were made per patient, with 82% classified as clinically significant and 4% potentially preventing major organ failure or similar. 94% of interventions were accepted.
•Average number of medications reduced from 12 to 11 and 92% of reviews resulted in more appropriate medication use.
•Patient reported outcome measures (PROMs) indicated improved understanding, adherence and reduced adverse effects.

•Economic evaluation identified a positive return on investment as well as a reduction in carbon footprint of both admissions and wastage of medicines.

The iSIMPATHY approach is transferable and the evidence produced supports robust policy development. Barriers such as competing priorities and workforce capacity must be addressed which can effectively be done through the change management tools.
Patient awareness and empowerment to be active participants in the review is crucial.
Research Areas Health and wellbeing

New ways of facing the challenge of polypharmacy,. Key Note. 27th Congress of the Spanish Society of Primary Care Pharmacists, Girona, Spain
2024

Description 27th Congress of the Spanish Society of Primary Care Pharmacists that will take place in Girona on May 2024 under the motto “Adding strengths, overcoming adversities, enhancing the clinical role”.
Research Areas Public health
Research Themes Health

Polypharmacy and Frailty SIG
2023 - 2024

Description Introduction
Frailty is a distinctive health state related to the ageing process in which multiple body systems gradually lose their in-built reserves. A person living with frailty is vulnerable to significant, often sudden, changes in health and functional ability in response to what would usually be a minor stressor event or change such as a simple infection or an alteration in medication. They are more likely to experience side-effects of medication and their shorter life expectancy limits time to gain therapeutic benefit compared to adults without frailty. Therefore it is important to reduce medication induced harm in this group of adults. As Frailty varies from mild to severe, so that person centred decisions on medications is essential. The assessment of frailty, and level of frailty can therefore help guide decision making when starting new medication or reviewing current medication. This 60-minute workshop is a collaboration between two of IFICs SIGs: Polypharmacy and Adherence and Ageing & Frailty.
Research Areas Health and wellbeing
Research Themes Health
Org Units School of Health and Social Care

Clinical Pharmacy services to address Polypharmacy. Key Note. Polish Clinical Pharmacists Society, Warsaw, Poland
2023

Description Invited by the Polish Clinical Pharmacists Society for key note
Research Themes Health

Addressing Polypharmacy : Chief Medical Officer Realistic Medicine Annual Conference, Scotland
2023

Research Themes Health

GP Pharmacist Collaborative working to address medication safety. Key note. Medication Safety Symposium, University of Munich.
2023

Description For Medication Safety conference organised by the university of Munich
Research Areas Public health
Research Themes Health

Integrated care approach to address Polypharmacy. Key note. German Medication Safety Conference, University of Cologne
2023

Description German Medication Safety Conference organised by the University of Cologne
Research Areas Public health

Implementing Policy to Implement Polypharmacy reviews across EU. European Society of Clinical Pharmacy- key note and workshop. Prague 2022
2022

Description European Society of Clinical Pharmacy- key note and workshop
Research Areas Health and wellbeing
Research Themes Health

Key Note: Polypharmacy and Adherence: BEAMER, Spain
2022

Research Areas Public health

Key Note: WHO challenge and Polypharmacy : European HealthCare Alliance, Brussels
2022

Research Areas Public health